Cargando…

Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer

BACKGROUND: Wnt factors control cell differentiation through semi-independent molecular cascades known as the β-catenin-dependent (canonical) and -independent (non-canonical) Wnt signalling pathways. Genetic and epigenetic alteration of components of the canonical Wnt signalling pathway is one of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lara, Ester, Calvanese, Vincenzo, Huidobro, Covadonga, Fernández, Agustin F, Moncada-Pazos, Ángela, Obaya, Álvaro J, Aguilera, Oscar, González-Sancho, José Manuel, Sánchez, Laura, Astudillo, Aurora, Muñoz, Alberto, López-Otín, Carlos, Esteller, Manel, Fraga, Mario F
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903502/
https://www.ncbi.nlm.nih.gov/pubmed/20591152
http://dx.doi.org/10.1186/1476-4598-9-170
_version_ 1782183805471162368
author Lara, Ester
Calvanese, Vincenzo
Huidobro, Covadonga
Fernández, Agustin F
Moncada-Pazos, Ángela
Obaya, Álvaro J
Aguilera, Oscar
González-Sancho, José Manuel
Sánchez, Laura
Astudillo, Aurora
Muñoz, Alberto
López-Otín, Carlos
Esteller, Manel
Fraga, Mario F
author_facet Lara, Ester
Calvanese, Vincenzo
Huidobro, Covadonga
Fernández, Agustin F
Moncada-Pazos, Ángela
Obaya, Álvaro J
Aguilera, Oscar
González-Sancho, José Manuel
Sánchez, Laura
Astudillo, Aurora
Muñoz, Alberto
López-Otín, Carlos
Esteller, Manel
Fraga, Mario F
author_sort Lara, Ester
collection PubMed
description BACKGROUND: Wnt factors control cell differentiation through semi-independent molecular cascades known as the β-catenin-dependent (canonical) and -independent (non-canonical) Wnt signalling pathways. Genetic and epigenetic alteration of components of the canonical Wnt signalling pathway is one of the primary mechanisms underlying colon cancer. Despite increasing evidence of the role of the non-canonical pathways in tumourigenesis, however, the underlying molecular mechanisms are poorly understood. RESULTS: Here we report that the receptor tyrosine kinase-like orphan receptor 2 (ROR2), a transmembrane receptor for Wnt factors that activates non-canonical pathways, is frequently repressed by aberrant promoter hypermethylation in human colon cancer cell lines and primary tumours. By restoring ROR2 activity in colon cancer cells harbouring ROR2 promoter hypermethylation, we show that the role of ROR2 in colon cancer cells is mediated, at least in part, by canonical Wnt and that its epigenetic-dependent loss can be pro-tumourigenic. CONCLUSIONS: Our data show the importance of epigenetic alterations of ROR2 in colon cancer, highlighting the close interconnection between canonical and non-canonical Wnt signalling pathways in this type of tumour.
format Text
id pubmed-2903502
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29035022010-07-14 Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer Lara, Ester Calvanese, Vincenzo Huidobro, Covadonga Fernández, Agustin F Moncada-Pazos, Ángela Obaya, Álvaro J Aguilera, Oscar González-Sancho, José Manuel Sánchez, Laura Astudillo, Aurora Muñoz, Alberto López-Otín, Carlos Esteller, Manel Fraga, Mario F Mol Cancer Research BACKGROUND: Wnt factors control cell differentiation through semi-independent molecular cascades known as the β-catenin-dependent (canonical) and -independent (non-canonical) Wnt signalling pathways. Genetic and epigenetic alteration of components of the canonical Wnt signalling pathway is one of the primary mechanisms underlying colon cancer. Despite increasing evidence of the role of the non-canonical pathways in tumourigenesis, however, the underlying molecular mechanisms are poorly understood. RESULTS: Here we report that the receptor tyrosine kinase-like orphan receptor 2 (ROR2), a transmembrane receptor for Wnt factors that activates non-canonical pathways, is frequently repressed by aberrant promoter hypermethylation in human colon cancer cell lines and primary tumours. By restoring ROR2 activity in colon cancer cells harbouring ROR2 promoter hypermethylation, we show that the role of ROR2 in colon cancer cells is mediated, at least in part, by canonical Wnt and that its epigenetic-dependent loss can be pro-tumourigenic. CONCLUSIONS: Our data show the importance of epigenetic alterations of ROR2 in colon cancer, highlighting the close interconnection between canonical and non-canonical Wnt signalling pathways in this type of tumour. BioMed Central 2010-06-30 /pmc/articles/PMC2903502/ /pubmed/20591152 http://dx.doi.org/10.1186/1476-4598-9-170 Text en Copyright ©2010 Lara et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Lara, Ester
Calvanese, Vincenzo
Huidobro, Covadonga
Fernández, Agustin F
Moncada-Pazos, Ángela
Obaya, Álvaro J
Aguilera, Oscar
González-Sancho, José Manuel
Sánchez, Laura
Astudillo, Aurora
Muñoz, Alberto
López-Otín, Carlos
Esteller, Manel
Fraga, Mario F
Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
title Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
title_full Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
title_fullStr Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
title_full_unstemmed Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
title_short Epigenetic repression of ROR2 has a Wnt-mediated, pro-tumourigenic role in colon cancer
title_sort epigenetic repression of ror2 has a wnt-mediated, pro-tumourigenic role in colon cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903502/
https://www.ncbi.nlm.nih.gov/pubmed/20591152
http://dx.doi.org/10.1186/1476-4598-9-170
work_keys_str_mv AT laraester epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT calvanesevincenzo epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT huidobrocovadonga epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT fernandezagustinf epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT moncadapazosangela epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT obayaalvaroj epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT aguileraoscar epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT gonzalezsanchojosemanuel epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT sanchezlaura epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT astudilloaurora epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT munozalberto epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT lopezotincarlos epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT estellermanel epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer
AT fragamariof epigeneticrepressionofror2hasawntmediatedprotumourigenicroleincoloncancer